Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Therapeutic Solutions International, Inc. (TSOI)
USD0.00
+0.00 (+0.00%)
US OTC Healthcare Biotechnology
Address
701 Wild Rose Lane 83525
Elk City, ID, US
Elk City, ID, US
CEO
Timothy George Dixon
Website
therapeuticsolutionsint.com
IPO
2008-06-24
CIK 1419051 ISIN US8833781011
Description
Therapeutic Solutions International, Inc. is dedicated to modulating the immune system to address a diverse array of serious conditions. The company formulates immune-modulatory agents targeting cancers, schizophrenia, suicidal ideation, and various neurological disorders like traumatic brain injury and chronic traumatic encephalopathy, alongside lung pathologies and general health maintenance. Its premier product, QuadraMune, is a patented, synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone, engineered to amplify natural killer cell activity and foster healthy cytokine production. In addition to QuadraMune, the company provides a range of nutraceuticals. These include ProJuvenol, an anti-aging capsule blend; various pterostilbene formulations like NanoStilbene (a nanoemulsion), DermalStilbene (a topical spray), IsoStilbene (an injectable form), and NeuroStilbene (an intranasal version); Nano Cannabidiol, a nanoparticle cannabidiol, and its composite NanoPlus (with NanoStilbene); as well as specialized blends such as NanoPSA (combining NanoStilbene and broccoli sprout extract) and the NLRP3 Trifecta (a two-product system with NanoPSA and GTE-50 green tea extract). Furthermore, the company is actively developing advanced therapeutics for chronic traumatic encephalopathy, traumatic brain injury, and lung diseases. Founded in 2007, Therapeutic Solutions International, Inc. is headquartered in Elk City, Idaho.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.00
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
0.47
Float Shares
4.56B
Free Float %
89.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +9,900.00% | +9,900.00% | +0.00% | -96.83% | -99.81% | -98.49% | -99.96% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.00
Quality scores
Altman Z-Score
-12.03
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
0 / 10
No MOAT
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-52.1% Q3'24: -99.9% (vs Q3'23)
-
EPS growth Biotechnology: +29.7%+53.3% ★ Q3'24: +99.9% (vs Q3'23)
-
FCF margin FCF growth · Biotechnology: +16.2%-1,681.4% Q3'24: +360.2% (vs Q3'23)
-
EBIT margin Biotechnology: +0.0%-1,817.5% Q3'24: -9,808.7% (vs Q3'23)
-
ROIC Biotechnology: -16.1%-84.0% Q3'24: -177.9% (vs Q3'23)
-
Share dilution Biotechnology: -3.4%+25.4% Q3'24: +49.5% (vs Q3'23)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.60× Q3'24: -0.13× (vs Q3'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-71.37M
OE per share TTM
-0.02
Owner's Yield
-1,452,701.54%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
213.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
7
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | James P. Boyd | 233.35M | 76.40% | 9.36M | 223.99M | 9.36M | 10.00 | IN | United States | 2012-09-04 | ↗ |
| 2 | ( | 217.50M | 24.71% | 217.50M | — | 217.50M | — | IN | USA | 2018-05-07 | ↗ |
| 3 | John Peck, Jr. | 175.00M | 21.70% | 175.00M | — | 175.00M | 10.00 | IN | USA | 2017-10-31 | ↗ |
| 4 | EIN: 30-0711202 | 149.40M | 5.96% | 149.40M | — | 149.40M | — | OO | Delaware, United States | 2022-04-20 | ↗ |
| 5 | ROBERT F. GRAHAM | 102.50M | 15.20% | 102.50M | — | 102.50M | — | IN | USA | 2016-07-08 | ↗ |
| 6 | Tad Mailander | 7.53M | 9.00% | — | — | 7.53M | — | IN | United States | 2013-04-30 | ↗ |
| 7 | 26-3962511 | 4.69M | 5.60% | — | 4.69M | — | 4.69M | IN | Nevada US | 2013-04-19 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
6
Sells
0
Shares acquired
130.56M
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+130,555,555
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | Ichim Thomas | Director | A-Award | A | Common Stock | 10,000,000 | 0.00 | 9.0K | 207,000,000 | D | ↗ |
| 2024-09-30 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 55,555,555 | 0.00 | 50.0K | 563,239,133 | D | ↗ |
| 2024-07-11 | Ichim Thomas | Director | A-Award | A | Common Stock | 10,000,000 | 0.00 | 6.0K | 197,000,000 | — | ↗ |
| 2024-07-11 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 20,000,000 | 0.00 | 12.0K | 507,683,578 | — | ↗ |
| 2024-07-08 | Ichim Thomas | Director | A-Award | A | Common Stock | 10,000,000 | 0.00 | 8.0K | 187,000,000 | — | ↗ |
| 2024-07-08 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 25,000,000 | 0.00 | 20.0K | 474,350,245 | — | ↗ |
| 2024-05-30 | Ichim Thomas | Director | A-Award | A | Common Stock | 10,000,000 | 0.00 | 8.0K | 177,000,000 | — | ↗ |
| 2024-05-30 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 37,500,000 | 0.00 | 30.0K | 449,350,245 | — | ↗ |
| 2024-04-18 | Ichim Thomas | Director | A-Award | A | Common Stock | 15,000,000 | 0.00 | 10.5K | 167,000,000 | — | ↗ |
| 2024-04-18 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 42,857,142 | 0.00 | 30.0K | 411,850,245 | — | ↗ |
| 2024-02-26 | Ichim Thomas | Director | A-Award | A | Common Stock | 10,000,000 | 0.00 | 9.0K | 152,000,000 | — | ↗ |
| 2024-02-26 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 10,000,000 | 0.00 | 9.0K | 368,993,103 | — | ↗ |
| 2023-10-16 | Ichim Thomas | Director | A-Award | A | Common Stock | 20,000,000 | 0.00 | 30.0K | 142,000,000 | — | ↗ |
| 2023-10-16 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 70,000,000 | 0.00 | 105.0K | 358,993,103 | — | ↗ |
| 2023-01-05 | Ichim Thomas | Director | A-Award | A | Common Stock | 4,000,000 | 0.00 | 19.6K | 122,000,000 | — | ↗ |
| 2023-01-05 | DIXON TIMOTHY G | Officer | A-Award | A | Common Stock | 4,081,632 | 0.00 | 20.0K | 288,993,103 | — | ↗ |
| 2022-12-30 | Ichim Thomas | Director | A-Award | A | Common Stock | 4,000,000 | 0.01 | 24.0K | 118,000,000 | — | ↗ |
| 2022-12-30 | DIXON TIMOTHY G | Officer | A-Award | A | Common Stock | 4,000,000 | 0.01 | 24.0K | 284,911,471 | — | ↗ |
| 2022-11-02 | Ichim Thomas | Director | A-Award | A | Common Stock | 3,000,000 | 0.01 | 29.7K | 114,000,000 | — | ↗ |
| 2022-11-02 | DIXON TIMOTHY G | Officer | A-Award | A | Common Stock | 3,777,777 | 0.01 | 37.4K | 280,911,471 | — | ↗ |
| 2022-09-09 | DIXON TIMOTHY G | Officer | G-Gift | D | Common Stock | 1,500,000 | 0.01 | 16.5K | 277,133,694 | — | ↗ |
| 2022-09-08 | DIXON TIMOTHY G | Director / Officer / 10% Owner | G-Gift | D | Common Stock | 1,500,000 | 0.01 | 17.4K | 279,633,694 | — | ↗ |
| 2022-04-11 | DIXON TIMOTHY G | Officer | G-Gift | D | Common Stock | 2,400,000 | 0.03 | 60.2K | 285,533,694 | — | ↗ |
| 2022-04-08 | DIXON TIMOTHY G | Director / Officer / 10% Owner | G-Gift | D | Common Stock | 2,400,000 | 0.03 | 60.2K | 285,533,694 | — | ↗ |
| 2022-04-05 | Ichim Thomas | Director | A-Award | A | Common Stock | 2,000,000 | 0.03 | 50.2K | 164,000,000 | — | ↗ |
| 2022-04-05 | DIXON TIMOTHY G | Officer | A-Award | A | Common Stock | 2,000,000 | 0.03 | 50.2K | 287,933,694 | — | ↗ |
| 2021-12-31 | Ichim Thomas | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-31 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 1,034,482 | 0.03 | 30.0K | 285,933,694 | — | ↗ |
| 2021-11-30 | Ichim Thomas | Director | A-Award | A | Common Stock | 2,500,000 | 0.03 | 80.0K | 162,000,000 | — | ↗ |
| 2021-11-30 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 2,500,000 | 0.03 | 80.0K | 284,899,212 | — | ↗ |
| 2021-09-30 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 796,875 | 0.05 | 40.8K | 282,399,212 | — | ↗ |
| 2021-06-18 | Ichim Thomas | Director / Officer | A-Award | A | Common Stock | 1,000,000 | 0.05 | 46.4K | 158,000,000 | — | ↗ |
| 2021-06-18 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 2,821,120 | 0.05 | 130.9K | 281,602,337 | — | ↗ |
| 2021-04-08 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 923,728 | 0.06 | 54.5K | 278,781,217 | — | ↗ |
| 2021-03-10 | Ichim Thomas | Director / Officer | G-Gift | A | Common Stock | 5,000,000 | 0.07 | 365.0K | 157,000,000 | — | ↗ |
| 2021-01-21 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 4,800,000 | 0.01 | 60.0K | 277,857,489 | — | ↗ |
| 2020-12-30 | Ichim Thomas | Director / Officer | A-Award | A | Common Stock | 3,000,000 | 0.01 | 18.0K | 162,000,000 | — | ↗ |
| 2020-12-30 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 3,000,000 | 0.01 | 18.0K | 273,057,489 | — | ↗ |
| 2020-12-17 | Ichim Thomas | Director / Officer | A-Award | A | Common Stock | 5,000,000 | 0.01 | 33.5K | 159,000,000 | — | ↗ |
| 2020-12-17 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 5,000,000 | 0.01 | 33.5K | 270,057,489 | — | ↗ |
| 2020-10-02 | Ichim Thomas | Director / Officer | A-Award | A | Common Stock | 5,000,000 | 0.01 | 43.0K | 154,000,000 | — | ↗ |
| 2020-10-02 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 5,000,000 | 0.01 | 43.0K | 265,057,489 | — | ↗ |
| 2020-09-30 | Ichim Thomas | Director / Officer | A-Award | A | Common Stock | 5,000,000 | 0.01 | 35.5K | 149,000,000 | — | ↗ |
| 2020-09-30 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 5,000,000 | 0.01 | 35.5K | 260,057,489 | — | ↗ |
| 2020-07-31 | Ichim Thomas | Director / Officer | A-Award | A | Common Stock | 3,000,000 | 0.01 | 23.1K | 144,000,000 | — | ↗ |
| 2020-07-31 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 3,000,000 | 0.01 | 23.1K | 255,057,489 | — | ↗ |
| 2020-07-17 | Ichim Thomas | Director | A-Award | A | Common Stock | 2,500,000 | 0.01 | 15.8K | 141,000,000 | — | ↗ |
| 2020-07-17 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 2,500,000 | 0.01 | 16.0K | 252,057,489 | — | ↗ |
| 2020-06-24 | Ichim Thomas | Director | A-Award | A | Common Stock | 5,000,000 | 0.01 | 41.5K | 138,500,000 | — | ↗ |
| 2020-06-24 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 10,000,000 | 0.01 | 83.0K | 249,557,489 | — | ↗ |
| 2020-06-12 | Ichim Thomas | Director / Officer | A-Award | A | Common Stock | 1,500,000 | 0.02 | 25.5K | 135,000,000 | — | ↗ |
| 2020-06-12 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 1,500,000 | 0.02 | 25.5K | 245,057,489 | — | ↗ |
| 2020-06-10 | Ichim Thomas | Director / Officer | A-Award | A | Common Stock | 10,000,000 | 0.00 | 46.0K | 133,500,000 | — | ↗ |
| 2020-06-10 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 10,000,000 | 0.00 | 46.0K | 244,557,489 | — | ↗ |
| 2020-06-08 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 18,181,818 | 0.00 | 60.0K | 234,557,489 | — | ↗ |
| 2020-06-03 | Ichim Thomas | Director / Officer | A-Award | A | Common Stock | 25,000,000 | 0.00 | 52.5K | 123,500,000 | — | ↗ |
| 2020-06-03 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 25,000,000 | 0.00 | 52.5K | 216,375,671 | — | ↗ |
| 2020-01-06 | Ichim Thomas | Director / Officer | A-Award | A | Common Stock | 50,000,000 | 0.00 | 65.0K | 98,500,000 | — | ↗ |
| 2020-01-06 | DIXON TIMOTHY G | Director / Officer / 10% Owner | G-Gift | D | Common Stock | 10,000,000 | 0.00 | 13.0K | 191,475,671 | — | ↗ |
| 2019-01-03 | Ichim Thomas | Director | A-Award | A | Common Stock | 15,000,000 | 0.01 | 75.0K | 59,500,000 | — | ↗ |
| 2019-01-03 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 15,000,000 | 0.01 | 75.0K | 136,475,671 | — | ↗ |
| 2019-01-03 | BERG GERRY B | Director / Officer / 10% Owner | A-Award | A | Common Stock | 15,000,000 | 0.01 | 75.0K | 122,750,001 | — | ↗ |
| 2016-10-18 | Ichim Thomas | Director | — | D | Common Stock | 0 | 0.00 | — | 44,500,000 | — | ↗ |
| 2016-10-18 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 15,000,000 | 0.00 | 67.5K | 121,475,671 | — | ↗ |
| 2016-10-18 | BERG GERRY B | Director / Officer / 10% Owner | A-Award | A | Common Stock | 10,000,000 | 0.00 | 45.0K | 107,750,001 | — | ↗ |
| 2016-02-02 | DIXON TIMOTHY G | Director / Officer / 10% Owner | G-Gift | D | Common Stock | 5,000,000 | 0.00 | 10.0K | 106,475,671 | — | ↗ |
| 2016-02-02 | BERG GERRY B | Director / Officer / 10% Owner | G-Gift | D | Common Stock | 12,250,000 | 0.00 | 24.5K | 97,750,001 | — | ↗ |
| 2014-11-28 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 63,936,736 | 0.00 | 127.9K | 111,475,671 | — | ↗ |
| 2014-11-28 | BERG GERRY B | Director / Officer / 10% Owner | A-Award | A | Common Stock | 55,744,665 | 0.00 | 111.5K | 110,000,001 | — | ↗ |
| 2014-06-23 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | Common Stock | 45,000,000 | 0.00 | 135.0K | 63,936,736 | — | ↗ |
| 2014-06-23 | BERG GERRY B | Director / Officer / 10% Owner | A-Award | A | Common Stock | 45,000,000 | 0.00 | 135.0K | 54,505,336 | — | ↗ |
| 2014-04-01 | DIXON TIMOTHY G | Director / Officer / 10% Owner | S-Sale | D | COMMON STOCK | 530,714 | 0.00 | 1.7K | 18,936,736 | — | ↗ |
| 2014-03-26 | DIXON TIMOTHY G | Director / Officer / 10% Owner | S-Sale | D | COMMON STOCK | 400,000 | 0.00 | 1.6K | 19,467,450 | — | ↗ |
| 2014-03-26 | BERG GERRY B | Director / Officer / 10% Owner | S-Sale | D | COMMON STOCK | 1,094,664 | 0.00 | 3.7K | 10,005,336 | — | ↗ |
| 2013-08-16 | BERG GERRY B | Director / Officer / 10% Owner | S-Sale | D | COMMON STOCK | 600,000 | 0.01 | 4.8K | 11,100,000 | — | ↗ |
| 2013-08-15 | DIXON TIMOTHY G | Director / Officer / 10% Owner | S-Sale | D | COMMON STOCK | 763,950 | 0.01 | 7.0K | 19,867,450 | — | ↗ |
| 2013-06-29 | GLASSMAN BARRY | Officer | A-Award | A | STOCK OPTION | 1,000,000 | 0.01 | 10.0K | 1,000,000 | — | ↗ |
| 2013-06-29 | DIXON TIMOTHY G | Director / Officer / 10% Owner | A-Award | A | CONVERTIBLE NOTE | 5,000,000 | 0.01 | 50.0K | 5,000,000 | — | ↗ |
| 2013-06-29 | BERG GERRY B | Director / Officer / 10% Owner | A-Award | A | CONVERTIBLE NOTE | 9,000,000 | 0.01 | 90.0K | 9,000,000 | — | ↗ |
| 2013-02-11 | GLASSMAN BARRY | Officer | — | I | Common Stock | 0 | 0.00 | — | 233,169 | — | ↗ |
| 2013-01-17 | BOYD JAMES P | 10% Owner | S-Sale | D | Common Stock | 223,991,933 | 0.00 | 336.0K | 8,500,000 | — | ↗ |
| 2012-08-24 | DIXON TIMOTHY G | Director / Officer | J-Other | A | Common Stock | 5,000,000 | 0.01 | 25.0K | 5,000,000 | — | ↗ |
| 2012-08-24 | BOYD JAMES P | 10% Owner | J-Other | D | Common Stock | 5,000,000 | 0.01 | 25.0K | 232,491,993 | — | ↗ |
| 2011-11-28 | BOYD JAMES P | Director / 10% Owner | — | D | Stock Option | 1,800,000 | 0.08 | 144.0K | 0 | — | ↗ |
| 2011-11-21 | DIXON TIMOTHY G | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 15,868,400 | — | ↗ |
| 2011-11-21 | BERG GERRY B | Officer | — | D | Stock Option | 1,500,000 | 0.08 | 120.0K | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-6.0K
Shares Outstanding
5.12B
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Timothy George Dixon | Chairman, Chief Executive Officer, President & Chief Financial Officer | 240.0K | male |
| Famela Ramos | Vice President of Business Development | — | female |
| Feng Lin | Chief Scientific Officer | — | — |
| James Drew Veltmeyer | Chief Medical Officer, Vice Chairman of CTE Advisory Board & Member of Scientific Advisory Board | — | — |
| Serena Robella | Director of Sales | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TSOI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
